SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017401
Filing Date
2022-08-15
Accepted
2022-08-15 16:57:22
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-20220630.htm   iXBRL 10-Q 2530105
2 EX-31.1 life-ex31_1.htm EX-31.1 13949
3 EX-31.2 life-ex31_2.htm EX-31.2 14052
4 EX-32.1 life-ex32_1.htm EX-32.1 10014
5 EX-32.2 life-ex32_2.htm EX-32.2 9375
  Complete submission text file 0000950170-22-017401.txt   7731795

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20220630_pre.xml EX-101.PRE 257994
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20220630.xsd EX-101.SCH 39345
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT life-20220630_cal.xml EX-101.CAL 46472
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT life-20220630_def.xml EX-101.DEF 140841
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20220630_lab.xml EX-101.LAB 357250
45 EXTRACTED XBRL INSTANCE DOCUMENT life-20220630_htm.xml XML 1385992
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 221166442
SIC: 2836 Biological Products, (No Diagnostic Substances)